Clinical trial
Safety and Efficacy of γIFN Treatment in Friedreich Ataxia
NCT03888664 is registered in ClinicalTrials.gov with IRCCS Eugenio Medea as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of γIFN Treatment in Friedreich Ataxia
- Lead sponsor
- IRCCS Eugenio Medea
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 26, 2016
- Completion date
- December 31, 2017
- Enrollment
- 12 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.